JUN 09, 2022 8:00 AM PDT

Dopamine's Effects on Emotion Regulation

WRITTEN BY: Kerry Charron

A study published in the Journal of Neuroscience indicated that emotional recognition processes in disorders such as Parkinson’s disease may be impacted by dopamine level changes in the brain. Several neurological conditions such as depression, schizophrenia, and Parkinson’s disease are characterized by dopamine disruption. Although previous research studies have found that dopamine plays a key role in memory, mood, movement, and motivation, this is the first study to connect dopamine with the ability to recognize emotions in others. 

Dopamine is a neurotransmitter that carries signals controlling mental and emotional responses in the brain. It is known as the “happy hormone” because it is activated during pleasurable experiences. Low dopamine levels can negatively affect the social skills necessary for effective social interactions. 

University of Birmingham researchers showed manipulated levels of dopamine by testing study participants’ working memory by asking them to gauge the emotions of a series of figures in three different video clips. The participants engaged in two separate tests. The researchers gave participants haloperidol (a commonly used pharmaceutical to treat mental and mood disorders) in the first test and a placebo in the second test. The figures in the video clips portrayed only the outline of the figure walking to emphasize three different gaits and postures denoting happy, angry, and sad emotions. Researchers found the dopamine boost improved the emotion recognition of individuals with lower dopamine baseline levels, but the haloperidol dose impaired the emotion recognition abilities of those with higher baseline levels. 

The study showed that even small doses of dopamine affect how the brain processes functions related to movement and emotion. According to lead author Dr. Bianca Schuster, this discovery has “important implications for fine tuning a patient's medicine regime to ensure a balance between controlling their symptoms and preserving social functions." Dopamine drug development could potentially enhance the well-being and relationships of those individuals struggling with social functioning. Individuals with low baseline dopamine decreased their own walking pace under haloperidol. Future research will explore the connection between how dopamine influences movement and emotion recognition.  

Sources: 

Journal of Neuroscience, Science Daily

 

About the Author
BA and MA in English, MPS in Human Relations, and Ed.D. in Higher Education Administration
Kerry Charron writes about medical cannabis research. She has experience working in a Florida cultivation center and has participated in advocacy efforts for medical cannabis.
You May Also Like
NOV 08, 2022
Technology
People say too much screen time is bad for kids. But is it really the problem?
NOV 08, 2022
People say too much screen time is bad for kids. But is it really the problem?
Screen time is a parent’s conundrum. How much screen time is too much? How do I adequately monitor my child’ ...
NOV 16, 2022
Health & Medicine
C360 Psilocybin Lessens Treatment-Resistant Depression Symptoms
NOV 16, 2022
C360 Psilocybin Lessens Treatment-Resistant Depression Symptoms
Researchers found that psilocybin may have potential as a treatment for those suffering from extreme depression. Psilocy ...
NOV 29, 2022
Cardiology
High-Salt Diets May Cause Increased Stress
NOV 29, 2022
High-Salt Diets May Cause Increased Stress
A new study suggests that high-salt diets increase circulating stress hormones.
DEC 03, 2022
Neuroscience
Hibiscus Treatments to Minimize Alzheimer's Disease Symptoms
DEC 03, 2022
Hibiscus Treatments to Minimize Alzheimer's Disease Symptoms
Previous research has shown that hibiscus can boost the immune system, control blood pressure, and reduce body weight. N ...
DEC 02, 2022
Neuroscience
Scientists Identify Distinct Brain Networks Associated with Risk and Resilience in Depression
DEC 02, 2022
Scientists Identify Distinct Brain Networks Associated with Risk and Resilience in Depression
A study published in Brain found a link between the location of brain injury to levels of depression in patients followi ...
DEC 06, 2022
Drug Discovery & Development
The most expensive drug in the world, Hemgenix, approved at $3.5 million per dose
DEC 06, 2022
The most expensive drug in the world, Hemgenix, approved at $3.5 million per dose
On Tuesday, November 22nd, 2022, the United States Food and Drug Administration approved Hemgenix, a new drug to treat h ...
Loading Comments...